A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in plasmodium falciparum

Pharmacology and Therapeutics

Volumn 77, Issue 1, 1998, Pages 1-28

  Bray, Patrick G ^a   Ward, Stephen A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Chloroquine; Malaria; Multidrug resistance; P glycoprotein; Verapamil

Indexed keywords

CHLOROQUINE; QUINOLINE; VERAPAMIL;

CANCER CELL; COMPARATIVE STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; GENETICS; HUMAN; HYPOTHESIS; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PHENOMENOLOGY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; P-GLYCOPROTEIN; PLASMODIUM FALCIPARUM; QUINOLINES;

EID: 0031964307     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00083-1     Document Type: Review

References (257)

1. Adagu, I. S., Dias, F., Pinheiro, L., Rombo, L., Dorosario, V. and Warhurst, D. C. (1996) Guinea-bissau - association of chloroquine resistance of Plasmodium falciparum with the tyr86 allele of the multiple drug-resistance gene pfmdr1. Trans. R. Soc. Trop. Med. Hyg. 90: 90-91.
2. Adovelande, J., Bastide, B., Deleze, J. and Schrevel, J. (1993) Cytosolic free calcium in Plasmodium falciparum-infected erythrocytes and the effect of verapamil: a cytofluorometric study. Exp. Parasitol. 76: 247-258.
3. Akiyama, S., Shiraishi, N., Kuratomi, Y., Nakagawa, M. and Kuwano, M. (1986) Circumvention of multiple-drug resistance in human cancer-cells by thioridazine, trifluoperazine, and chlorpromazine. J. Natl. Cancer Inst. 76: 839-844.
4. - currents are activated by cell swelling but do not contribute to cell-volume regulation. Cancer Res. 54: 618-622.
5. Altenberg, G. A., Vanoye, C. G., Han, E. S., Deitmer, J. W. and Reuss, L. (1994b) Relationships between rhodamine-123 transport, cell-volume, and ion-channel function of P-glycoprotein. J. Biol. Chem. 269: 7145-7149.
6. Ambudkar, S. V. (1995) Purification and reconstitution of functional human P-glycoprotein. J. Bioenerg. Biomembr. 27: 23-29.
7. Asaumi, J., Kawasaki, S., Nishikawa, K., Kuroda, M. and Hiraki, Y. (1995a) Effects of hyperthermia and cephatanthin on adriamycin accumulation with changes in extracellular pH. Int. J. Hyperthermia 11: 27-35.
8. - exchanger on adriamycin accumulation. Anticancer Res. 15: 71-75.
9. + transport in toad bladder membrane-vesicles: evidence for 2 electrogenic transporters with different affinities toward pyrazinecarboxamides. J. Biol. Chem. 262: 8566-8573.
10. Awad el Kariem, F. M., Miles, M. A. and Warhurst, D. C. (1992) Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance. Trans. R. Soc. Trop. Med. Hyg. 86: 587-589.
11. 2+-entry blockers, neuroleptics and local-anesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukemic-cell line. Drugs Exp. Clin. Res. 20: 13-18.
12. Barnes, D. A., Foote, S. J., Galatis, D., Kemp, D. J. and Cowman, A. F. (1992) Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and incteased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11: 3067-3075.
13. Basco, L. K. and Le Bras, J. (1993) In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 48: 120-125.
14. Basco, L. K. and Le Bras, J. (1994) In-vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum. Jpn. J. Med. Sci. Biol. 47: 59-63.
15. Basco, L. K., Ringwald, P. and Le Bras, J. (1991) Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann. Trop. Med. Parasitol. 85: 223-228.
16. Basco, L. K., Le Bras, J., Rhoades, Z. and Wilson, C. M. (1995) Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Sub-Saharan Africa. Mol. Biochem. Parasitol. 74: 157-166.
17. Basco, L. K., Depecoulas, P. E., Le Bras, J. and Wilson, C. M. (1996) Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp. Parasitol. 82: 97-103.
18. Bayoumi, R. A., Babiker, H. A. and Arnot, D. E. (1994) Uptake and efflux of chloroquine by chloroquine-resistant Plasmodium falciparum clones recently isolated in Africa. Acta Trop. 58: 141-149.
19. Beck, W. T. (1987) The cell biology of multiple-drug resistance. Biochem. Pharmacol. 36: 2879-2887.
20. Beck, W. T., Cirtain, M. C. and Lefko, J. L. (1983) Energy-dependent reduced drug-binding as a mechanism of Vinca alkaloid resistance in human-leukemic lymphoblasts. Mol. Pharmacol. 24: 485-492.
21. Beck, W. T., Cirtain, M. C., Look, A. T. and Ashmun, R. A. (1986) Reversal of Vinca alkaloid resistance but not multiple-drug resistance in human-leukemic cells by verapamil. Cancer Res. 46: 778-784.
22. Bitonti, A. J., Sjoerdsma, A., McCann, P. P., Kyle, D. E., Oduola, A. M., Rossan, R. N., Milhous, W. K. and Davidson, D. E. (1988) Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science 242: 1301-1303.
23. Borst, P. and Ouellette, M. (1995) New mechanisms of drug-resistance in parasitic protozoa. Annu. Rev. Microbiol. 49: 427-460.
24. Boscoboinik, D., Gupta, R. S. and Epand, R. M. (1990) Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian-cells. Br. J. Cancer 61: 568-572.
25. Brasseur, P., Kouamouo, J., Moyousomo, R. and Druilhe, P. (1992) Multidrug resistant falciparum-malaria in Cameroon in 1987-1988: 2. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am. J. Trop. Med. Hyg. 46: 8-14.
26. Bray, P. G., Howells, R. E., Ritchie, G. Y. and Ward, S. A. (1992a) Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum: a correlation of chloroquine sensitivity with energy-dependent drug accumulation. Biochem. Pharmacol. 44: 1317-1324.
27. Bray, P. G., Howells, R. E. and Ward, S. A. (1992b) Vacuolar acidification and chloroquine sensitivity in Plasmodium falciparum. Biochem. Pharmacol. 43: 1219-1227.
28. Bray, P. G., Boulter, M. K., Ritchie, G. Y., Howells, R. E. and Ward, S. A. (1994) Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 63: 87-94.
29. Bray, P. G., Hawley, S. R., Mungthin, M. and Ward, S. A. (1996a) Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol. 50: 1559-1566.
30. Bray, P. G., Hawley, S. R. and Ward, S. A. (1996b) 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Mol. Pharmacol. 50: 1551-1558.
31. Broxterman, H. J., Jansen, G., Linn, S. C. and Lankelma, J. (1995) Drug Transport in Antimicrobial and Anticancer Chemotherapy, Vol. 1. Marcel Dekker, New York.
32. Candell, J., Valle, V. and Soler, M. (1979) Acute intoxification with verapamil. Chest 75: 200-201.
33. Cano-Gauci, D. F. and Riordan, J. R. (1987) Action of calcium antagonists on multidrug resistant cells: specific cytotoxicity independent of increased cancer drug accumulation. Biochem. Pharmacol. 36: 2115-2123.
34. Cano-Gauci, D. F., Busche, R., Tummler, B. and Riordan, J. R. (1990) Fast kinetic-analysis of drug transport in multidrug resistant cells using a pulsed quench-flow apparatus. Biochem. Biophys. Res. Commun. 167: 48-53.
35. Childs, G. E., Boudreau, E. F., Wimonwattratee, T., Pang, L. and Milhous, W. K. (1991) In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand. Am. J. Trop. Med. Hyg. 44: 553-559.
36. Chou, A. C., Chevli, R. and Fitch, C. D. (1980) Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19: 1543-1549.
37. Cornwell, M. M., Pastan, I. and Gottesman, M. M. (1987) Certain calcium-channel blockers bind specifically to multidrug-resistant human-KB carcinoma membrane-vesicles and inhibit drug-binding to P-glycoprotein. J. Biol. Chem. 262: 2166-2170.
38. Coutaux, A. F., Mooney, J. J. and Wirth, D. F. (1994) Neuronal monoamine reuptake inhibitors enhance in-vitro susceptibility to chloroquine in resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 38: 1419-1421.
39. Cowman, A. F., Karcz, S., Galatis, D. and Culvenor, J. G. (1991) A P-glycoprotein homolog of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 113: 1033-1042.
40. Cowman, A. F., Galatis, D. and Thompson, J. K. (1994) Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA 91: 1143-1147.
41. Dalmark, M. and Hoffmann, E. K. (1982) Doxorubicin (adriamycin) transport in nucleated and non-nucleated cells shows features of a simple diffusion transport process. Proc. Am. Assoc. Cancer Res. 23: 4.
42. Dalmark, M. and Hoffmann, E. K. (1983) Doxorubicin (adriamycin) transport in Ehrlich ascites tumor-cells: comparison with transport in human red-blood-cells. Scand. J. Clin. Lab. Invest. 43: 241-248.
43. Dalmark, M. and Storm, H. H. (1981) A Fickian diffusion transport process with features of transport catalysis: doxorubicin transport in human red blood-cells. J. Gen. Physiol. 78: 349-364.
44. Danö, K. (1973) Active outward transport of daunomycin in resistant Erlich ascites tumor cells. Biochim. Biophys. Acta 323: 466-483.
45. De, D., Bhaduri, A. P. and Milhous, W. K. (1993) A novel pyrrolidonoalkaneamine (WR268954) that modulates chloroquine resistance of Plasmodium falciparum in-vitro. Am. J. Trop. Med. Hyg. 49: 113-120.
46. De, D., Krogstad, F. M., Cogswell, F. B. and Krogstad, D. J. (1996) Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 55: 579-583.
47. Deloron, P., Basco, L. K., Dubois, B., Gandin, C., Clavier, F., Le Bras, J. and Verdier, F. (1991) In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine. Antimicrob. Agents Chemother. 35: 1338-1342.
48. Diddens, H., Gekeler, V., Neumann, M. and Niethammer, D. (1987) Characterization of actinomycin-D-resistant CHO cell-lines exhibiting a multidrug-resistance phenotype and amplified DNA-sequences. Int. J. Cancer 40: 635-642.
49. Diribe, C. O. and Warhurst, D. C. (1985) A study of the uptake of chloroquine in malaria-infected erythrocytes: high and low affinity uptake and the influence of glucose and its analogs. Biochem. Pharmacol. 34: 3019-3027.
50. Doige, C. A. and Ames, G. F. (1993) ATP-dependent transport-systems in bacteria and humans: relevance to cystic-fibrosis and multidrug-resistance. Annu. Rev. Microbiol. 47: 291-319.
51. Doige, C. A. and Sharom, F. J. (1992) Transport-properties of P-glycoprotein in plasma-membrane vesicles from multidrug-resistant Chinese-hamster ovary cells. Biochim. Biophys. Acta 1109: 161-171.
52. Domenech, C., Fierroduran, G., Rodriguez, L., Grauoliete, M. R. and Riverafillat, M. P. (1993) Vincristine cellular pharmacokinetic changes associated with multidrug-resistance. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 248: 49-58.
53. Dom, A., Stoffel, R., Matile, H., Bubendorf, A. and Ridley, R. G. (1995) Malarial haemozoin beta-hematin supports heme polymerization in the absence of protein. Nature 374: 269-271.
54. Draper, C. C., Hills, M., Kilimali, V. A. and Brubaker, G. (1988) Serial studies on the evolution of drug-resistance in malaria in an area of East-Africa: findings from 1979 up to 1986. J. Trop. Med. Hyg. 91: 265-273.
55. Ekons, R. M., Robson, K. J. H., Baker, D. A. and Warhorst, D. C. (1993) Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant Plasmodium falciporum. Parasitology. 106: 107-115.
56. Eytan, G. D., Regev, R. and Assaraf, Y. G. (1996a) Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. J. Biol. Chem. 271: 3172-3178.
57. Eytan, G. D., Regev, R., Oren, G. and Assaraf, Y. G. (1996b) The role of passive transbilayer drug movement in multidrug resistance and its modulation. J. Biol. Chem. 271: 12897-12902.
58. Ferguson, P. J., Phillips, J. R., Seiner, M. and Cass, C. E. (1984) Differential activity of vincristine and vinblastine against cultured-cells. Cancer Res. 44: 3307-3312.
59. Ferrari, V. and Cutler, D. J. (1990) Uptake of chloroquine by human erythrocytes. Biochem. Pharmacol. 39: 753-762.
60. Ferrari, V. and Cutler, D. J. (1991a) Kinetics and thermodynamics of chloroquine and hydroxychloroquine transport across the human erythrocyte-membrane. Biochem. Pharmacol. 41: 23-30.
61. Ferrari, V. and Cutler, D. J. (1991b) Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum: evidence for a drug-importer in chloroquine-sensitive strains. Biochem. Pharmacol. 42 (Suppl.): S167-S179.
62. Fitch, C. D. (1970) Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity. Science 169: 289-290.
63. Fitch, C. D. (1983) Mode of action of anti-malarial drugs. Ciba Found. Symp. 94: 222-228.
64. Fitch, C. D. (1986) Antimalarial schizontocides: ferriprotoporphyrin-IX interaction hypothesis. Parasitol. Today 2: 330-331.
65. Fitch, C. D., Chevli, R. and Gonzalez, Y. (1974) Chloroquine-resistant Plasmodium falciparum: effect of substrate on chloroquine and amodiaquin accumulation. Antimicrob. Agents Chemother. 6: 757-762.
66. Fitch, C. D., Chevli, R., Kanjananggulpan, P., Dutta, P., Chevli, K. and Chou, A. C. (1983) Intracellular ferriprotoporphyrin-IX is a lytic agent. Blood 62: 1165-1168.
67. Fojo, A., Akiyama, S., Gottesman, M. M. and Pastan, I. (1985a) Reduced drug accumulation in multiply drug-resistant human-KB carcinoma cell-lines. Cancer Res. 45: 3002-3007.
68. Fojo, A. T., Whangpeng, J., Gottesman, M. M. and Pastan, I. (1985b) Amplification of DNA-sequences in human multidrug-resistant KB carcinoma-cells. Proc. Natl. Acad, Sci. USA 82: 7661-7665.
69. Foley, M. and Tilley, L. (1997) Quinoline antimalarials: mechanisms of action and resistance. Int. J. Parasitol. 27: 231-240.
70. Foote, S. J., Thompson, J. K., Cowman, A. F. and Kemp, D. J. (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of Plasmodium falciparum. Cell 57: 921-930.
71. Foote, S. J., Kyle, D. E., Martin, R. K., Oduola, A. M., Forsyth, K., Kemp, D. J. and Cowman, A. F. (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
72. Ford, J. M. and Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42: 155-199.
73. Ford, J. M. and Hait, W. N. (1993) Pharmacological circumvention of multidrug-resistance. Cytotechnology 12: 171-212.
74. Ford, J. M., Bruggemann, E. P., Pastan, I., Gottesman, M. M. and Hait, W. N. (1990) Cellular and biochemical-characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell-lines. Cancer Res. 50: 1748-1756.
75. Frezard, F. and Garnier-Suillerot, A. (1991) Determination of the osmotic active-drug concentration in the cytoplasm of anthracycline-resistant and anthracycline-sensitive K562 cells. Biochim. Biophys. Acta 1091: 29-35.
76. Gabriel, S. E., Clarke, L. L., Boucher, R. C. and Stutts, M. J. (1993) CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature 363: 263-266.
77. Geary, T. G. and Jensen, J. B. (1983) Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro. J. Parasitol. 69: 97-105.
78. Geary, T. G., Jensen, J. B. and Ginshurg, H. (1986) Uptake of [H-3] chloroquine by drug-sensitive and drug-resistant strains of the human malaria parasite Plasmodium falciparum. Biochem. Pharmacol. 35: 3805-3812.
79. Geary, T. G., Divo, A. A. and Jensen, J. B. (1987) Activity of quinoline-containing antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 81: 499-503.
80. Geary, T. G., Divo, A. D., Jensen, J. B., Zangwill, M. and Ginsburg, H. (1990) Kinetic modeling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro: implications for mechanism of action of and resistance to the drug. Biochem. Pharmacol. 40: 685-691.
81. Georges, E., Sharom, F. J. and Ling, V. (1990) Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv. Pharmacol. 21: 185-220.
82. Gerena, L., Bass, G. T., Kyle, D. E., Oduola, A. M., Milhous, W. K. and Martin, R. K. (1992) Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 36: 2761-2765.
83. Gill, D. R., Hyde, S. C., Higgins, C. F., Valverde, M. A., Mintenig, G. M. and Sepulveda, F. V. (1992) Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71: 23-32.
84. Ginsburg, H. (1990) Antimalarial-drugs: is the lysosomotropic hypothesis still valid? Parasitol. Today 6: 334-337.
85. Ginsburg, H. (1991) Enhancement of the antimalarial effect of chloroquine on drug-resistant parasite strains: a critical-examination of the reversal of multidrug resistance. Exp. Parasitol. 73: 227-232.
86. Ginsburg, H. and Geary, T. G. (1987) Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials. Biochem. Pharmacol. 36: 1567-1576.
87. Ginsburg, H. and Stein, W. D. (1991) Kinetic modeling of chloroquine uptake by malaria-infected erythrocytes: assessment of the factors that may determine drug-resistance. Biochem. Pharmacol. 41: 1463-1470.
88. Ginsburg, H., Nissani, E. and Krugliak, M. (1989) Alkatinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochem. Pharmacol. 38: 2645-2654.
89. Goldberg, D. E., Slater, A. F., Cerami, A. and Henderson, G. B. (1990) Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc. Natl. Acad. Sci. USA 87: 2931-2935.
90. Gottesman, M. M. and Pastan, I. (1993) Biochemistry of multidrug-resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62: 385-427.
91. Gottesman, M. M., Currier, S., Bruggeman, E., Lelong, I., Stein, W. and Pastan, I. (1994) The multidrug transporter: mechanistic considerations. Curr. Top. Membr. 41: 3-17.
92. Gros, P., Benneriah, Y., Croop, J. M. and Housman, D. E. (1986a) Isolation and expression of a complementary-DNA that confers multidrug resistance. Nature 323: 728-731.
93. Gros, P., Croop, J. and Housman, D. (1986b) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380.
94. Gruber, A., Peterson, C. and Reizenstein, P. (1988) D-Verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic-cells in vitro. Int. J. Cancer 41: 224-226.
95. Haber, M., Norris, M. D., Kavallaris, M., Bell, D. R., Davey, R. A., White, L. and Stewart, B. W. (1989) Atypical multidrug resistance in a therapy-induced drug-resistant human-leukemia cell-line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res. 49: 5281-5287.
96. Hardy, S. P., Goodfellow, H. R., Valverde, M. A., Gill, D. R., Sepulveda, F. V. and Higgins, C. F. (1995) Protein-kinase C-mediated phosphorylation of the human multidrug-resistance P-glycoprotein regulates celt volume-activated chloride channels. EMBO J. 14: 68-75.
97. Harinasuta, T., Migasen, S. and Boonag, D. (1962) Chloroquine resistance in Plasmodium falciparum in Thailand. In: UNESCO First Regional Symposium on Scientific Knowledge of Tropical Parasites, pp. 148-153. University of Singapore, Singapore.
98. Harker, W. G., Bauer, D., Etiz, B. B., Newman, R. A. and Sikic, B. I. (1986) Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma-cells: selectivity for drugs which produce DNA scission. Cancer Res. 46: 2369-2373.
99. Haruki, K., Bray, P. G., Ward, S. A., Hommel, M. and Ritchie, G. Y. (1994) Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr1 gene. Trans. R. Soc. Trop. Med. Hyg. 88: 694.
100. Hasmann, M., Valet, G. K., Tapiero, H., Trevorrow, K. and Lampidis, T. (1989) Membrane-potential differences between adriamycin-sensitive and adriamycin-resistant cells as measured by flow-cytometry. Biochem. Pharmacol. 38: 305-312.
101. Hawley, S. R., Bray, P. G., O'Neill, P. M., Naisbitt, D. J., Park, B. K. and Ward, S. A. (1996a) Manipulation of the n-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Antimicrob. Agents Chemother. 40: 2345-2349.
102. Hawley, S. R., Bray, P. G., O'Neill, P. M., Park, B. K. and Ward, S. A. (1996b) The role of drug accumulation in 4-aminoquinoline antimatarial potency: the influence of structural substitution and physicochemical properties. Biochem. Pharmacol. 52: 723-733.
103. Hawley, S. R., Bray, P. G., Park, B. K. and Ward, S. A. (1996c) Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol. Biochem. Parasitol. 80: 15-25.
104. Higgins, C. F. (1992) ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8: 67-113.
105. Higgins, C. F. (1995) P-glycoprotein and cell volume-activated chloride channels. J. Bioenerg. Biomembr. 27: 63-70.
106. Hindenburg, A. A., Baker, M. A., Gleyzer, E., Stewart, V. J., Case, N. and Taub, R. N. (1987) Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug-resistance. Cancer Res. 47: 1421-1425.
107. Hindenburg, A. A., Gervasoni, J. E., Krishna, S., Stewart, V. J., Rosado, M., Lutzky, J., Bhalla, K., Baker, M. A. and Taub, R. N. (1989) Intracellular-distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and anthracycline-resistant HI-60 cells. Cancer Res. 49: 4607-4614.
108. Homewood, C. A., Warhurst, D. C., Peters, W. and Baggaley, V. C. (1972) Lysosomes, pH and the anti-malarial action of chloroquine. Nature (Lond.) 235: 50-52.
109. Homolya, L., Hollo, Z., Germann, U. A., Pastan, I., Gottesman, M. M. and Sarkadi, B. (1993) Fluorescent cellular indicators are extruded by the multidrug-resistance protein. J. Biol. Chem. 268: 21493-21496.
110. Horio, M., Gottesman, M. M. and Pastan, I. (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. USA 85: 3580-3584.
111. Horio, M., Lovelace, E., Pastan, I. and Gottesman, M. M. (1991) Agents which reverse multidrug-resistance are inhibitors of [H-3] vinblastine transport by isolated vesicles. Biochim. Biophys. Acta 1061: 106-110.
112. Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E. and Higgins, C. F. (1990) Structural model of ATP-binding proteins associated with cystic-fibrosis, multidrug resistance and bacterial transport. Nature 346: 362-365.
113. Inaba, M., Fujikura, R. and Sakurai, Y. (1981) Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia. Biochem. Pharmacol. 30: 1863-1865.
114. Inaba, M., Watanabe, T. and Sugiyama, Y. (1987) Kinetic-analysis of active efflux of vincristine from multidrug-resistant p388 leukemia-cells. Jpn. J. Cancer Res. 78: 397-404.
115. Jaffrezou, J. P., Chen, G., Duran, G. E., Muller, C., Bordier, C., Laurent, G., Sikic, B. I. and Levade, T. (1995) Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug-resistance. Biochim. Biophys. Acta Mol. Cell Res. 1266: 1-8.
116. Jirsch, J. D., Loe, D. W., Cole, S. P., Deeley, R. G. and Fedida, D. (1994) ATP is not required for anion current activated by cell swelling in multidrug-resistant lung-cancer cells. Am. J. Physiol. 267: C688-C699.
117. Kartner, N., Everndenporelle, D., Bradley, G. and Ling, V. (1985) Detection of P-glycoprotein in multidrug-resistant cell-lines by monoclonal-antibodies. Nature 316: 820-823.
118. Keizer, H. G. and Joenje, H. (1989) Increased cytosolic pH in multidrug-resistant human-lung tumor-cells: effect of verapamil. J. Natl. Cancer Inst. 81: 706-709.
119. Kessel, D. and Wilberding, C. (1985) Anthracycline resistance in P388 murine leukemia and its circumvention by calcium-antagonists. Cancer Res. 45: 1687-1691.
120. Krogstad, D. J. and Schlesinger, P. H. (1987) The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. Am. J. Trop. Med. Hyg. 36: 213-220.
121. Krogstad, D. J., Schlesinger, P. H. and Gluzman, I. Y. (1985) Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 101: 2302-2309.
122. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M., Martin, S. K., Milhous, W. K. and Schlesinger, P. H. (1987) Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
123. Krogstad, D. J., Gluzman, I. Y., Herwaldt, B. L., Schlesinger, P. H. and Wellems, T. E. (1992) Energy-dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem. Pharmacol. 43: 57-62.
124. Kyle, D. E., Oduola, A. M., Martin, S. K. and Milhous, W. K. (1990) Plasmodium falciparum: modulation by calcium-antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Trans. R. Soc. Trop. Med. Hyg. 84: 474-478.
125. Lankelma, J., Mülder, H. S., Vanmourik, F., Sang, H. W., Kraayenhof, R. and Vangrondelle, R. (1991) Cellular daunomycin fluorescence in multidrug resistant 2780AD cells and its relation to cellular-drug localization. Biochim. Biophys. Acta 1093: 147-152.
126. Lee, S. C., Deutsch, C. and Beck, W. T. (1988) Comparison of ion channels in multidrug-resistant and multidrug-sensitive human-leukemic cells. Proc. Natl. Acad. Sci. USA 85: 2019-2023.
127. Lee, W. P. (1995) Purification and characterization of tubulin from parental and vincristine-resistant hob1 lymphoma-cells. Arch. Biochem. Biophys. 319: 498-503.
128. Lelong, I. H., Padmanabhan, R., Lovelace, E., Pastan, I. and Gottesman, M. M. (1992) ATP and GTP as alternative energy-sources for vinblastine transport by P-170 in KB-V1 plasma-membrane vesicles. FEBS Lett. 304: 256-260.
129. Lim, A. S. and Cowman, A. F. (1996) Plasmodium falciparum: chloroquine selection of a cloned line and DNA rearrangements. Exp. Parasitol. 83: 283-294.
130. Lim, A. S., Galatis, D. and Cowman, A. F. (1996) Plasmodium folciparum: amplification and overexpression of pfmdr1 is not necessary for increased mefloquine resistance. Exp. Parasitol. 83: 295-303.
131. - currents in NIH/3T3 cells. Am. J. Physiol. 267: C650-C658.
132. 3 exchange in transfected Chinese-hamster ovary cells. Biophys. J. 66: A122.
133. +-exchange in Chinese-hamster ovary cells. Biochemistry 33: 7239-7249.
134. Martin, S. K., Oduola, A. M. and Milhous, W. K. (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901.
135. Martiney, J. A., Cerami, A. and Slater, A. F. (1995) Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J. Biol. Chem. 270: 22393-22398.
136. Michaelis, S., Kistler, A., Sapperstein, S., Chen, P. and Berkower, C. (1993) Molecular analysis of STE6, the yeast a-factor transporter. FASEB J. 7: A1195.
137. Moriyama, Y., Manabe, T., Yoshimori, T., Tashiro, Y. and Futai, M. (1994) ATP-dependent uptake of antineoplastic agents by acidic organelles. J. Biochem. 115: 213-218.
138. Mülder, H. S., Dekker, H., Pinedo, H. M. and Lankelma, J. (1995) The P-glycoprotein-mediated relative decrease in cytosolic-free drug concentration is similar for several anthracyclines with varying lipophilicity. Biochem. Pharmacol. 50: 967-974.
139. Nateghpour, M., Ward, S. A. and Howells, R. E. (1993) Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparum. Antimicrob. Agents Chemother. 37: 2337-2343.
140. Ndifor, A. M., Howells, R. E., Bray, P. G., Ngu, J. L. and Ward, S. A. (1993) Enhancement of drug susceptibility in Plasmodium falciparum in vitro and plasmodium-berghei in vivo by mixed-function oxidase-inhibitors. Antimicrob. Agents Chemother. 37: 1318-1323.
141. Ng, W. F., Sarangi, F., Zastawny, R. L., Veinot-Drebot, L. and Ling, V. (1989) Identification of members of the P-glycoprotein multigene family. Mol. Cell. Biol. 9: 1224-1232.
142. Nielsen, D. and Skovsgaard, T. (1992) P-glycoprotein as multidrug transporter: a critical-review of current multidrug resistant cell-lines. Biochim. Biophys. Acta 1139: 169-183.
143. Oduola, A. M., Milhous, W. K., Weatherly, N. F., Bowdre, J. H. and Desjardins, R. E. (1988) Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Exp. Parasitol. 67: 354-360.
144. Oduola, A. M., Omitowoju, G. O., Gerena, L., Kyle, D. E., Milhous, W. K., Sowunmi, A. and Salako, L. A. (1993) Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Trans. R. Soc. Trop. Med. Hyg. 87: 81-83.
145. Orjih, A. U., Banyal, H. S., Chevli, R. and Fitch, C. D. (1981) Hemin lyses malaria parasites. Science 214: 667-669.
146. Ortiz, D. F., Kreppel, L., Speiser, D. M., Scheel, G., McDonald, G. and Ow, D. W. (1992) Heavy-metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter. EMBO J. 11: 3491-3499.
147. Ozols, R. F. (1985) Pharmacologic reversal of drug-resistance in ovarian-cancer. Semin. Oncol. 12: 7-11.
148. Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V. and Willingham, M. C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA 85: 4486-4490.
149. Pedersen, P. L. (1995) Multidrug-resistance: a fascinating, clinically relevant problem in bioenergetics. J. Bioenerg. Biomembr. 27: 3-5.
150. Pedersen, P. L. and Amzel, L. M. (1993) ATP synthases: structure, reaction center, mechanism, and regulation of one of nature's most unique machines. J. Biol. Chem. 268: 9937-9940.
151. Peel, S. A., Merritt, S. C., Handy, J. and Baric, R. S. (1993) Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 48: 385-397.
152. Peel, S. A., Bright, P., Yount, B., Handy, J. and Baric, R. S. (1994) A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr1) of Plasmodium falciparum in-vitro. Am. J. Trop. Med. Hyg. 51: 648-658.
153. Peters, W., Ekong, R., Robinson, B. L., Warhurst, D. C. and Pan, X. Q. (1989) Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet 2: 334-335.
154. Ramu, A., Spanier, R., Rahamimoff, H. and Fuks, Z. (1984) Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukemia-cells. Br. J. Cancer 50: 501-507.
155. Ramu, A., Pollard, H. B. and Rosario, L. M. (1989) Doxorubicin resistance in P388 leukemia: evidence for reduced drug influx. Int. J. Cancer 44: 539-547.
156. Rasola, A., Galietta, L. J., Gruenert, D. C. and Romeo, G. (1994) Volume-sensitive chloride currents in 4 epithelial-cell lines are not directly correlated to the expression of the mdr-1 gene. J. Biol. Chem. 269: 1432-1436.
157. Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I. and Gottesman, M. M. (1990) Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor-cells. J. Biol. Chem. 265: 3975-3980.
158. Raymond, M., Gros, P., Whiteway, M. and Thomas, D. Y. (1992) Functional complementation of yeast-STE6 by a mammalian multidrug resistance mdr-gene. Science 256: 232-234.
159. Ridley, R. G., Hofheinz, W., Matile, H., Jaquet, C., Dorn, A., Masciadri, R., Jolidon, S., Richter, W. F., Guenzi, A., Girometta, M. A., Urwyler, H., Huber, W., Thaithong, S. and Peters, W. (1996) 4-Aminoquinoline analogs of chloroquine with shortened side-chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40: 1846-1854.
160. Riehm, H. and Biedler, J. L. (1972) Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res. 32: 1182-1195.
161. Riordan, J. R. and Ling, V. (1985) Genetic and biochemical characterization of multidrug resistance. Pharmacol. Ther. 28: 51-75.
162. Ritchie, G. Y., Mungthin, M., Green, J. E., Bray, P. G., Hawley, S. R. and Ward, S. A. (1996) In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pghl. Mol. Biochem. Parasitol. 83: 35-46.
163. Roepe, P. D. (1992) Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry 31: 12555-12564.
164. Roepe, P. D. (1995) The role of the MDR protein in altered drug translocation across tumor-cell membranes. Biochim. Biophys. Acta Rev. Biomembr. 1241: 385-405.
165. --dependent intracellular pH regulation in murine mdr-1 transfectants and potential implications. Biochemistry 33: 11008-11015.
166. Roepe, P. D., Wei, L. Y., Hoffman, M. M. and Fritz, F. (1996) Altered drug translocation mediated by the MDR protein: direct, indirect, or both. J. Bioenerg. Biomembr. 28: 541-555.
167. Roninson, I. B. (ed.) (1991) Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum, New York.
168. Rubio, J. P. and Cowman, A. F. (1994) Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite. Exp. Parasitol. 79: 137-147.
169. Rubio, J. P. and Cowman, A. F. (1996) The ATP-bonding cassette (ABC) gene family of Plasmodium falciparum. Parasitol. Today 12: 135-140.
170. Ruetz, S. and Gros, P. (1994a) Functional expression of P-glycoproteins in secretory vesicles. J. Biol. Chem. 269: 12277-12284.
171. Ruetz, S. and Gros, P. (1994b) A mechanism for P-glycoprotein action in rnultidrug-resistance: are we there yet? Trends Pharmacol. Sci. 15: 260-263.
172. Ruetz, S., Raymond, M. and Gros, P. (1993) Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast-cells. Proc. Natl. Acad. Sci. USA 90: 11588-11592.
173. Ruetz, S., Celling, U., Brault, M., Schurr, E. and Gros, P. (1996) The pfmdr1 gene of Plasmodium falciparum confers cellular-resistance to antimalarial-drugs in yeast-cells. Proc. Natl. Acad. Sci. USA 93: 9942-9947.
174. Sanchez, C. P., Wunsch, S. and Lanzer, M. (1997) Identification of a chloroquine importer in Plasmodium falciparum: differences in import kinetics are genetically linked with the chloroquine-resistant phenotype. J. Biol. Chem. 272: 2652-2658.
175. Sardini, A., Mintenig, G. M., Valverde, M. A., Sepulveda, F. V., Gill, D. R., Hyde, S. C., Higgins, C. F. and McNaughton, P. A. (1994a) Cell swelling inhibits drug efflux from cells expressing the multidrug-resistance phenotype. J. Physiol. 475: P95-P96.
176. Sardini, A., Mintenig, G. M., Valverde, M. A., Sepulveda, F. V., Gill, D. R., Hyde, S. C., Higgins, C. F. and McNaughton, P. A. (1994b) Drug efflux mediated by the human multidrug-resistance P-glycoprotein is inhibited by cell swelling. J. Cell Sci. 107 (Pt. 12) 3281-3290.
177. Schlemmer, S. R. and Sirotnak, F. M. (1994) Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3: properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. J. Biol. Chem. 269: 31059-31066. Erratum: J. Biol. Chem. 270: 34621 (1995).
178. Schuurhuis, G. J., Broxterman, H. J., Cervantes, A., Vanheijningen, T. H., Delange, J. H., Baak, J. P., Pinedo, H. M. and Lankelma, J. (1989) Quantitative-determination of factors contributing to doxorubicin resistance in multidrug-resistant cells. J. Natl. Cancer Inst. 81: 1887-1892.
179. Scotto, K. W., Biedler, J. L. and Melera, P. W. (1986) Amplification and expression of genes associated with multidrug resistance in mammalian-cells. Science 232: 751-755.
180. Seeber, S., Osieka, R., Schmidt, C. G., Achterrath, W. and Crooke, S. T. (1982) In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II). Cancer Res. 42: 4719-4725.
181. Senior, A. E., Alshawi, M. K. and Urbatsch, I. L. (1995) ATP hydrolysis by multidrug-resistance protein from Chinese-hamster ovary cells. J. Bioenerg. Biomembr. 27: 31-36.
182. Shapiro, A. B. and Ling, V. (1995a) Using purified P-glycoprotein to understand multidrug-resistance. J. Bioenerg. Biomembr. 27: 7-13.
183. Shapiro, A. B. and Ling, V. (1995b) Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270: 16167-16175.
184. Sharom, F. J. (1995) Characterization and functional reconstitution of the multidrug transporter. J. Bioenerg. Biomembr. 27: 15-22.
185. Sharom, F. J., Yu, X. H. and Doige, C. A. (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268: 24197-24202.
186. Shen, D. W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I. and Gottesman, M. M. (1986) Human multidrug-resistant cell-lines: increased mdr1 expression can precede gene amplification. Science 232: 643-645.
187. Siegfried, J. M., Burke, T. G. and Tritton, T. R. (1985) Cellular-transport of anthracyclines by passive diffusion: implications for drug-resistance. Biochem. Pharmacol. 34: 593-598.
188. Simon, S., Roy, D. and Schindler, M. (1994) Intracellular pH and the control of multidrug-resistance. Proc. Natl. Acad. Sci. USA 91: 1128-1132.
189. Sirotnak, F. M., Yang, C. H., Mines, L. S., Oribe, E. and Biedler, J. L. (1986) Markedly altered membrane-transport and intracellular binding of vincristine in multidrug-resistant Chinese-hamster cells selected for resistance to Vinca alkaloids. J. Cell. Physiol. 126: 266-274.
190. Skovsgaard, T. (1977) Transport and binding of daunorubicin, adriamycin and rubidazone in Erlich ascites tumor cells. Biochem. Pharrnacol. 26: 215-222.
191. Skovsgaard, T. (1978) Mechanisms of resistance to daunorubicin in Erlich ascites tumor cells. Cancer Res. 38: 1785-1791.
192. Slater, A. F. (1993) Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol. Ther. 57: 203-235.
193. Slater, A. F. and Cerami, A. (1992) Inhibition by chloroquine of a novel heme polymerase enzyme-activity in malaria trophozoites. Nature 355: 167-169.
194. Slater, L. M., Murray, S. L., Wetzel, M. W., Wisdom, R. M. and Duvall, E. M. (1982) Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites-carcinoma. J. Clin. Invest. 70: 1131-1134.
195. Sowunmi, A., Oduola, A. M., Salako, L. A., Ogundahunsi, O. A., Laoye, O. J. and Walker, O. (1992) The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans. R. Soc. Trop. Med. Hyg. 86: 368-371.
196. Spoelstra, E. C., Westerhoff, H. V., Dekker, H. and Lankelma, J. (1992) Kinetics of daunorubicin transport by P-glycoprotein of intact cancer-cells. Eur. J. Biochem. 207: 567-579.
197. Stein, W. D., Cardarelli, C., Pastan, I. and Gottesman, M. M. (1994) Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol. Pharmacol. 45: 763-772.
198. Stow, M. W. and Warr, J. R. (1993) Reduced influx is a factor in accounting for reduced vincristine accumulation in certain verapamil-hypersensitive multidrug-resistant CHO cell-lines. FEBS Lett. 320: 87-91.
199. Su, X., Kirkman, L. A. and Wellems, T. E. (1996) Changes in genes from chromosome 7 of Plasmodium falciparum show high degree linkage to chloroquine responses. Am. J. Trop. Med. Hyg. 61: 242.
200. Suebsaeng, L., Wernsdorfer, W. H. and Rooney, W. (1986) Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand. Bull. WHO 64: 759-765.
201. Sullivan, D. J., Jr., Gluznan, I. Y., Russell, D. G. and Goldberg, D. E. (1996) On the molecular mechanism of chloroqume's antimalarial action. Proc. Natl. Acad. Sci. USA 93: 11865-11870.
202. Tarasiuk, J. and Garnier-Suillerot, A. (1992) Kinetic-parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cells. Eur. J. Biochem. 204: 693-698.
203. Teem, J. L., Berger, H. A., Ostedgaard, L. S., Rich, D. P., Tsui, L. C. and Welsh, M. J. (1993) Identification of revertants for the cystic-fibrosis delta-f508 mutation using ste6-cftr chimeras in yeast. Cell 73: 335-346.
204. Thaithong, S., Suebsaeng, L., Rooney, W. and Beale, G. H. (1988) Evidence of increased chloroquine sensitivity in Thai isolates of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 82: 37-38.
205. Thiebaut, F., Currier, S. J., Whitaker, J., Haugland, R. P., Gottesman, M. M., Pastan, I. and Willingham, M. C. (1990) Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by micro injection of a pH-sensitive dye. J. Histochem. Cytochem. 38: 685-690.
206. Trezise, A. E., Romano, P. R., Gill, D. R., Hyde, S. C., Sepulveda, F. V., Buchwald, M. and Higgins, C. F. (1992) The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J. 11: 4291-4303.
207. Triggle, D. J. and Swamy, V. C. (1983) Calcium antagonists: some chemical-pharmacological aspects. Circ. Res. 52: 17-28.
208. Triglia, T., Foote, S. J., Kemp, D. J. and Cowman, A. F. (1991) Implication of the multidrug resistance gene pfmdr1 in Plasmodium falciparum has arisen as multiple independent events. Mol. Cell. Biol. 11: 5244-5250.
209. Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y. (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cyto-toxicity of vincristine and vinblastine by veraparnil. Cancer Res. 41: 1967-1972.
210. Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y. (1982) Increased accumulation of vincristine and adriamycin in drug-resistant P388-tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 42: 4730-4733.
211. Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y. (1983) Potentiation of vincristine and adriamycin in human hematopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res. 43: 2267-2272.
212. Tsuruo, T., Iida, H., Kawabata, H., Tsukagoshi, S. and Sakurai, Y. (1984) High calcium content of pleiotropic drug-resistant tumor-cells. Proc. Am. Assoc. Cancer Res. 25: 335.
213. Tsuruo, T., Kawabata, H., Nagumo, N., Iida, H., Kitatani, Y., Tsukagoshi, S. and Sakurai, Y. (1985) Potentiation of antitumor agents by calcium-channel blockers with special reference to cross-resistance patterns. Cancer Chemother. Pharmacol. 15: 16-19.
214. Twentyman, P. R., Fox, N. E. and Bleehen, N. M. (1986) Drug-resistance in human-lung cancer cell-lines: cross-resistance studies and effects of the calcium-transport blocker, verapamil. Int. J. Radiat. Oncol. Biol. Phys. 12: 1355-1358.
215. Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V. and Riordan, J. R. (1986) The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 141: 956-962.
216. Ueda, K., Cardarelli, C., Gottesman, M. M. and Pastan, I. (1987a) Expression of a full-length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 84: 3004-3008.
217. Ueda, K., Clark, D. P., Chen, C., Roninson, I. B., Gottesman, M. M. and Pastan, I. (1987b) The human multidrug resistance (mdr1) gene: cDNA cloning and transcription initiation. J. Biol. Chem. 262: 505-508.
218. Ullman, B. (1995) Multidrug-resistance and P-glycoproteins in parasitic protozoa. J. Bioenerg. Biomembr. 27: 77-84.
219. Valverde, M. A., Diaz, M., Sepulveda, F. V., Gill, D. R., Hyde, S. C. and Higgins, C. F. (1992) Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355: 830-833.
220. Van der Kaay, H. J., Wernsdorfer, W. H. and Froeling, F. M. (1985) In vitro response of Plasmodium falciparum to mefloquine: studies conducted in West and East-Africa. Ann. Soc. Belge Med. Trop. 65 (Suppl. 2): 147-153.
221. Van Es, H. H., Karcz, S., Chu, F., Cowman, A. F., Vidal, S., Gros, P. and Schurr, E. (1994a) Expression of the plasmodial pfmdr1 gene in mammalian-cells is associated with increased susceptibility to chloroquine. Mol. Cell. Biol. 14: 2419-2428.
222. Van Es, H. H., Renkema, H., Aerts, H. and Schurr, E. (1994b) Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene. Mol. Biochem. Parasitol. 68: 209-219.
223. Verdier, F., Le Bras, J., Clavier, F., Hatin, I. and Blayo, M. C. (1985) Chloroquine uptake by Plasmodium falciparum-infected human-erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob. Agents Chemother. 27: 561-564.
224. Volkman, S. K. and Wirth, D. F. (1996) Analysis of Pghl expression in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61: 244.
225. Volkman, S. K., Wilson, C. M. and Wirth, D. F. (1993) Stage-specific transcripts of the Plasmodium falciparum-pfmdr-1 gene. Mol. Biochem. Parasitol. 57: 203-212.
226. Volkman, S. K., Cowman, A. F. and Wirth, D. F. (1995) Functional complementation of the ste6 gene of Saccharomyces-cerevisiae with the pfmdr1 gene of Plasmodium-falciparum. Proc. Natl. Acad. Sci. USA 92: 8921-8925.
227. Walter, R. D., Seth, M. and Bhaduri, A. P. (1993) Reversal of chloroquine resistance in Plasmodium falciparum by cdr-8 7/209 and analogs. Trop. Med. Parasitol. 44: 5-8.
228. Wang, X. Y., Wall, D. M., Parkin, J. D., Zalcberg, J. R. and Kemm, R. E. (1994) P-glycoprotein expression in classical multidrug, resistant leukemia-cells does not correlate with enhanced chloride channel activity. Clin. Exp. Pharmacol. Physiol. 21: 101-108.
229. Warhurst, D. C. (1986) Antimalarial schizontocides: why a permease is necessary. Parasitol. Today 2: 331-334.
230. Warr, J. R., Brewer, F., Anderson, M. and Fergusson, J. (1986) Verapamil hypersensitivity of vincristine resistant Chinese-hamster ovary cell-lines. Cell Biol. Int. Rep. 10: 389-399.
231. Warr, J. R., Anderson, M. and Fergusson, J. (1988) Properties of verapamil-hypersensitive rnultidrug-resistant Chinese-hamster ovary cells. Cancer Res. 48: 4477-4483.
232. Warsame, M., Wernsdorfer, W. H., Payne, D. and Bjorkman, A. (1991) Susceptibility of Plasmodium falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine pyrimethamine in Somalia - relationships between the responses to the different drugs. Trans. R. Soc. Trop. Med. Hyg. 85: 565-569.
233. Waters, A. P., Wirth, D. F., Wellems, T. E. and Delportillo, H. A. (1996) Transfection of malaria parasites. Parasitol. Today 12: 129-132.
234. Weaver, J. L., Pine, P. S., Aszalos, A., Schoenlein, P. V., Currier, S. J., Padmanabhan, R. and Gottesman, M. M. (1991) Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine-123 in multidrug-resistant cells. Exp. Cell Res. 196: 323-329.
235. Wei, L. Y., Stutts, M. J., Huffman, M. M. and Roepe, P. D. (1995) Overexpression of the cystic-fibrosis transmembrane conductance regulator in NIH 3T3 cells lowers membrane-potential and intracellular pH and confers a multidrug-resistance phenotype. Biophys. J. 69: 883-895.
236. Wellems, T. E., Panton, L. J., Gluzman, I. Y., Dorosario, V. E., Gwadz, R. W., Walkerjonah, A. and Krogstad, D. J. (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
237. Wernsdorfer, W. H. (1994) Epidemiology of drug-resistance in malaria. Acta Trop. 56: 143-156.
238. Wernsdorfer, W. H., Landgraf, B., Wiedermann, G. and Kollaritsch, H. (1994) Inverse correlation of sensitivity in-vitro of Plasmodium falciparum to chloroquine and mefloquine in Ghana. Trans. R. Soc. Trop. Med. Hyg. 88: 443-444.
239. WHO (1957) Expert Committee on Malaria. Sixth Report, WHO Technical Report Series, No. 123. World Health Organisation, Geneva.
240. WHO (1995) Special Program for Research and Training in Tropical Diseases (TDR). Twelfth Program Report. World Health Organisation, Geneva.
241. Willingham, M. C., Cornwell, M. M., Cardarelli, C. O., Gottesman, M. M. and Pastan, I. (1986a) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and multidrug-sensitive KB cells: effects of verapamil and other drugs. Cancer Res. 46: 5941-5946.
242. Willingham, M. C., Cornwell, M., Gottesman, M. G. and Pastan, I. (1986b) The multidug resistance phenotype in mutant human carcinoma-cells: cytochemical detection of altered accumulation and efflux of daunomycin. J. Histochem. Cytochem. 34: 1365.
243. Wilson, C. M., Serrano, A. E., Wasley, A., Bogenschutz, M. P., Shankar, A. H. and Wirth, D. F. (1989) Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244: 1184-1186.
244. Wilson, C. M., Volkman, S. K., Thaithong, S., Martin, R. K., Kyle, D. E., Milhous, W. K. and Wirth, D. F. (1993) Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57: 151-160.
245. Wongsrichanalai, C., Webster, M. K., Wimonwattrawatee, T., Sookto, S., Chuanak, N., Thimasarn, K. and Wernsdoreer, W. M. (1992) Emergence of multi-drug resistant Plasmodium falciparum in Thailand. In vitro tracking. Am. J. Trop. Med. Hyg. 47: 112-116.
246. Yayon, A., Cabantchik, Z. I. and Ginsburg, H. (1984a) Identification of the acidic compartment of Plasmodium falciparum-infected human-erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3: 2695-2700.
247. Yayon, A., Cabantchik, Z. I. and Ginsburg, H. (1984b) pH-dependent sensitivity of human malaria parasites to chloroquine. J. Protozool. 31: A82-A83.
248. Yayon, A., Timberg, R., Friedman, S. and Ginsburg, H. (1984c) Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J. Protozool. 31: 367-372.
249. Yayon, A., Cabantchik, Z. I. and Ginsburg, H. (1985) Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. USA 82: 2784-2788.
250. Ye, Z. G. and Van Dyke, K. (1988) Reversal of chloroquine resistance in falciparum-malaria independent of calcium channels. Biochem. Biophys. Res. Commun. 155: 476-481.
251. Ye, Z. G. and Van Dyke, K. (1994) Reversal of chloroquine resistance in falciparum-malaria by some calcium-channel inhibitors and optical isomers is independent of calcium-channel blockade. Drug Chem. Toxicol. 17: 149-162.
252. Zalis, M. G., Wilson, C. M., Zhang, Y. and Wirth, D. F. (1993) Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 62: 83-92.
253. Zamora, J. M. and Beck, W. T. (1986) Chloroquine enhancement of anticancer drug cyto-toxicity in multiple-drug resistant human-leukemic cells. Biochem. Pharmacol. 35: 4303-4310.
254. Zamora, J. M., Pearce, H. L. and Beck, W. T. (1988) Physical-chemical properties shared by compounds that modulate multidrug resistance in human-leukemic cells. Mol. Pharmacol. 33: 454-462.
255. Zeuthen, T. and Stein, W. D. (1994) Cotransport of salt and water in membrane-proteins: membrane-proteins as osmotic engines. J. Memb. Bio. 137: 179-195.
256. Zhang, Y. and Hempelmann, E. (1987) Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins. Biochem. Pharmacol. 36: 1267-1273.
257. Zhang, Y. and Just, W. W. (1987) A comparative-study on the effect of chloroquine and ammonium-chloride on feeding process of Plasmodium falciparum in vitro. Z. Parasitenk. 73: 475-478.